KinderFarms

KinderFarms

Private
Redondo Beach, CaliforniaHealthcare & Life Scienceshttps://www.kinderfarms.com

Last Round

Series B

Sep 28, 2023

Total Funding Raised

$42.5M

Momentum Score

50 /100

Company Overview

KinderFarms is a health and wellness company co-founded by actress Jessica Biel and entrepreneur Jeremy Adams. The company's mission is to provide families with clean and effective health products. It manufactures and sells over-the-counter (OTC) medicines for children under the brand KinderMed, and oral electrolyte solutions for families under the brand KinderLyte. KinderFarms' products are formulated without artificial sweeteners, flavors, or colors, and are non-GMO, vegan, and gluten-free. The company is privately held and has received private equity backing, including a Series B funding round in 2023. Its products are available in over 30,000 stores nationwide.

Sector

Healthcare & Life Sciences

Verticals

D2C Brands, E-commerce, Home & Lifestyle

Business Model

B2B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

children's OTC medicinekids medicineoral electrolyte solutionclean label productsno artificial ingredientschildren's health productsconsumer packaged goodsCPGdirect-to-consumerD2Ckids nutrition shakesplant-based protein shakescelebrity-founded brandsubscription model

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

KinderFarms Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

KinderFarms Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BSep 28, 2023
Series ASep 11, 2023

Key People

Founding team and executive leadership

Kristin Recchiuti

Chief Executive Officer

Executive Team

KinderFarms Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 26, 2025

    Launched KinderMed Pain & Fever product line for family health.

  • Jun 1, 2025

    Partnered with KRC Research to survey 1,000 parents.

KinderFarms Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

KinderFarms Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about KinderFarms's valuation, stock price, and market status.

Firmographic Details

HeadquartersRedondo Beach, California
Employee Range12
Year Founded2016
Last FundingSep 28, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.